Journals / International Journal of Innovative Research and Reviews / 2022 / Volume: 6 Issue: 2

Parkinson's Disease, Therapy with Drugs and Nanotechnology

Kaan Küçükoğlu(SELCUK UNIVERSITY)
Hayrunnisa Nadaroglu(ATATURK UNIVERSITY)
Pages
—
Publication Date
2022-12-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When a great effort continues to discover new drugs having different action mechanisms, it is expected that developed nanotechnology-based drugs for PD therapy become important, additionally.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Parkinson's disease (PD) is a disorder that destroys neurons in the extrapyramidal dopaminergic pathway in the brain.
📊
Key Findings & Data:In the world, the number of patients with PD is 10 million now and PD is a disease whose incidence increases with age.
💡
Conclusion & Impact:When a great effort continues to discover new drugs having different action mechanisms, it is expected that developed nanotechnology-based drugs for PD therapy become important, additionally.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Parkinson · Symptoms · Therapy

Abstract

Parkinson's disease (PD) is a disorder that destroys neurons in the extrapyramidal dopaminergic pathway in the brain. In the world, the number of patients with PD is 10 million now and PD is a disease whose incidence increases with age. In particular, genetic and environmental factors are believed to cause PD. Rigidity in striated muscles, characteristic tremors and posture disorder are specified as main clinical symptoms of PD. Although radical treatment of PD is not possible today, some drugs that slow the progression of it and effective on its symptoms are used successfully in the clinic. Among them, the essential drug is levodopa. However, an important disadvantage in the drug treatment of PD is that the beneficial effects of the drugs decrease over time in long-term use. Moreover, the use of them is associated with serious side effects. Therefore, it is important to develop new treatment strategies in the treatment of PD. When a great effort continues to discover new drugs having different action mechanisms, it is expected that developed nanotechnology-based drugs for PD therapy become important, additionally.

🔖

Cite This Article

Küçükoğlu, K., Nadaroglu, H. (2022). Parkinson's Disease, Therapy with Drugs and Nanotechnology. International Journal of Innovative Research and Reviews, Volume: 6 Issue: 2. https://ajindex.com/articles/1496420

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...